Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1451-1458

  Moon, Myung Hee ^a   Jeong, Jae Kyo ^a   Lee, You Jin ^a   Seol, Jae Won ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Chondrocyte; Cyclooxygenase 2; Inflammation; Prostaglandin E2; Sphingosine 1 phosphate

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; COLLAGENASE 3; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; PROSTAGLANDIN E2; RECEPTOR BLOCKING AGENT; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STROMELYSIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; W 146;

ARTICLE; CARTILAGE CELL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTI-INFLAMMATORY AGENTS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2; DRUG EVALUATION, PRECLINICAL; ENZYME INDUCTION; EXTRACELLULAR MATRIX; HUMANS; INTERLEUKIN-1BETA; KNEE JOINT; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASES, SECRETED; OSTEOARTHRITIS, KNEE; PROTEOLYSIS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; TRANSCRIPTION FACTOR RELA;

EID: 84869469917     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1135     Document Type: Article

References (32)

1. Chabane N, Zayed N, Afif H, et al: Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 16: 1267-1274, 2008.
2. Goldring MB and Marcu KB: Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 11: 224, 2009.
3. Goldring MB and Berenbaum F: Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage 7: 386-388, 1999. (Pubitemid 29331556)
4. Kim HA, Yeo Y, Kim WU and Kim S: Phase II enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes. Rheumatology (Oxford) 48: 932-938, 2009.
5. Lianxu C, Hongti J and Changlong Y: NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14: 367-376, 2006. (Pubitemid 44268926)
6. Pelletier JP, Martel-Pelletier J and Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44: 1237-1247, 2001. (Pubitemid 32537520)
7. Kopp EB and Ghosh S: NF-kappa B and rel proteins in innate immunity. Adv Immunol 58: 1-27, 1995.
8. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
9. Newton R, Kuitert LM, Bergmann M, Adcock IM and Barnes PJ: Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 237: 28-32, 1997. (Pubitemid 27390317)
10. Shakibaei M, Csaki C, Nebrich S and Mobasheri A: Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76: 1426-1439, 2008.
11. Johnstone ED, Chan G, Sibley CP, Davidge ST, Lowen B and Guilbert LJ: Sphingosine-1-phosphate inhibition of placental trophoblast differentiation through a G(i)-coupled receptor response. J Lipid Res 46: 1833-1839, 2005. (Pubitemid 41248479)
12. Schuppel M, Kurschner U, Kleuser U, Schafer-Korting M and Kleuser B: Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol 128: 1747-1756, 2008. (Pubitemid 351847385)
13. Pyne S and Pyne NJ: Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349: 385-402, 2000. (Pubitemid 30465772)
14. Stradner MH, Hermann J, Angerer H, et al: Sphingosine-1- phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes. Osteoarthritis Cartilage 16: 305-311, 2008. (Pubitemid 351309177)
15. Ogawa R, Takahashi M, Hirose S, et al: A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis. Biochem Biophys Res Commun 361: 621-628, 2007. (Pubitemid 47238032)
16. Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P and Hedrick CC: Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 102: 950-958, 2008. (Pubitemid 351591554)
17. Seol JW, Lee HB, Kim NS and Park SY: Tartrate-resistant acid phosphatase as a diagnostic factor for arthritis. Int J Mol Med 24: 57-62, 2009.
18. Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40: 1-11, 1999.
19. Thomas CM, Fuller CJ, Whittles CE and Sharif M: Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 15: 27-34, 2007. (Pubitemid 46117914)
20. Dave M, Attur M, Palmer G, et al: The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 58: 2786-2797, 2008.
21. Liacini A, Sylvester J, Li WQ, et al: Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288: 208-217, 2003. (Pubitemid 36871010)
22. Wood DD, Ihrie EJ, Dinarello CA and Cohen PL: Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 26: 975-983, 1983. (Pubitemid 13039816)
23. Largo R, Alvarez-Soria MA, Diez-Ortego I, et al: Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11: 290-298, 2003. (Pubitemid 36410882)
24. Amin AR, Dave M, Attur M and Abramson SB: COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2: 447-453, 2000.
25. Reginster JY, Deroisy R, Rovati LC, et al: Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357: 251-256, 2001. (Pubitemid 32120855)
26. Singh R, Ahmed S, Islam N, Goldberg VM and Haqqi TM: Epigallocatechin-3- gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 46: 2079-2086, 2002.
27. Burrage PS, Mix KS and Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci 11: 529-543, 2006. (Pubitemid 43258162)
28. Martel-Pelletier J, Welsch DJ and Pelletier JP: Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15: 805-829, 2001. (Pubitemid 34092514)
29. Shakibaei M, John T, Schulze-Tanzil G, Lehmann I and Mobasheri A: Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol 73: 1434-1445, 2007. (Pubitemid 46452591)
30. Barnes PJ and Karin M: Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997. (Pubitemid 27163860)
31. Suomalainen L, Pentikäinen V and Dunkel L: Sphingosine-1- phosphate inhibits nuclear factor κB activation and germ cell apoptosis in the human testis independently of its receptors. Am J Pathol 166: 773-781, 2005. (Pubitemid 40315634)
32. Masuko K, Murata M, Nakamura H, Yudoh K, Nishioka K and Kato T: Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes. BMC Musculoskelet Disord 8: 29, 2007.